Mirae Asset Global Investments Co. Ltd. Has $2.11 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 16.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,390 shares of the exchange traded fund’s stock after purchasing an additional 2,997 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in SPDR S&P Biotech ETF were worth $2,113,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in XBI. ORG Partners LLC bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $40,000. ORG Wealth Partners LLC acquired a new position in SPDR S&P Biotech ETF during the third quarter worth $44,000. Waldron Private Wealth LLC bought a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at $54,000. Resources Management Corp CT ADV lifted its holdings in shares of SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after acquiring an additional 138 shares during the period. Finally, Lynx Investment Advisory acquired a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at $58,000.

SPDR S&P Biotech ETF Stock Down 0.1 %

Shares of SPDR S&P Biotech ETF stock opened at $98.42 on Thursday. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The stock has a market capitalization of $7.50 billion, a P/E ratio of 11.47 and a beta of 1.11. The company has a 50-day simple moving average of $98.99 and a 200 day simple moving average of $94.80.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.